Cargando…
A promising “TRAIL” of tanshinones for cancer therapy
An ideal cancer therapy specifically targets cancer cells while sparing normal tissues. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) elicits apoptosis by engaging its cognate death receptors (DRs—namely, DR4 and DR5. The cancer cell-selective proapoptotic action of TRAIL is highly...
Autores principales: | Ho, Tsing-Fen, Chang, Chia-Che |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
China Medical University
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664605/ https://www.ncbi.nlm.nih.gov/pubmed/26621311 http://dx.doi.org/10.7603/s40681-015-0023-8 |
Ejemplares similares
-
Nano-TRAIL: a promising path to cancer therapy
por: Gampa, Siri Chandana, et al.
Publicado: (2023) -
Tanshinone IIA: A Promising Natural Cardioprotective Agent
por: Shang, Qinghua, et al.
Publicado: (2012) -
Molecular Mechanism of Tanshinone against Prostate Cancer
por: Li, Wei, et al.
Publicado: (2022) -
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
por: Zhang, Yong, et al.
Publicado: (2012) -
TRAIL combinations: The new ‘trail’ for cancer therapy (Review)
por: REFAAT, ALAA, et al.
Publicado: (2014)